Fundraising Fox
Iconovo
Sweden, SE · 1 known investors
Find your way into Iconovo
Sign up to see every warm intro you have to Iconovo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iconovo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.
Founders & leadership
OL
Orest LastowFounderOrest Lastow is founder of Iconovo, which develops dry powder inhalation platforms and formulations for pharmaceutical delivery. He holds expertise in aerosol science, device development, and inhalation technology, and teaches aerosol drug delivery at Lund University.
Investors · 1
In the news
Frequently asked questions
- What does Iconovo do?
- Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.
- Who founded Iconovo?
- Iconovo was founded by Orest Lastow.
- Who are Iconovo's investors?
- Iconovo's investors include FSG.
- Where is Iconovo headquartered?
- Iconovo is headquartered in Sweden, SE.